Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Operating Margin (2016 - 2025)

Historic Operating Margin for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to 7.86%.

  • OptimizeRx's Operating Margin rose 480400.0% to 7.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.17%, marking a year-over-year increase of 382000.0%. This contributed to the annual value of 14.88% for FY2024, which is 220400.0% up from last year.
  • OptimizeRx's Operating Margin amounted to 7.86% in Q3 2025, which was up 480400.0% from 10.92% recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Operating Margin ranged from a high of 11.25% in Q4 2024 and a low of 54.32% during Q1 2023
  • Moreover, its 5-year median value for Operating Margin was 19.93% (2024), whereas its average is 15.76%.
  • Per our database at Business Quant, OptimizeRx's Operating Margin crashed by -340400bps in 2023 and then soared by 496800bps in 2024.
  • OptimizeRx's Operating Margin (Quarter) stood at 3.06% in 2021, then crashed by -244bps to 4.4% in 2022, then crashed by -774bps to 38.43% in 2023, then surged by 129bps to 11.25% in 2024, then crashed by -30bps to 7.86% in 2025.
  • Its Operating Margin was 7.86% in Q3 2025, compared to 10.92% in Q2 2025 and 9.64% in Q1 2025.